Have a personal or library account? Click to login
Effectiveness of Ropeginterferon Alfa-2B in High-Risk Patients with Philadelphia Chromosome Negative Myeloproliferative Neoplasms– Evaluation of Clinicohaematologic Response, and Safety Profile: Single Centre Experience Cover

Effectiveness of Ropeginterferon Alfa-2B in High-Risk Patients with Philadelphia Chromosome Negative Myeloproliferative Neoplasms– Evaluation of Clinicohaematologic Response, and Safety Profile: Single Centre Experience

PRILOZI
Volume 44 (2023): Issue 3 (December 2023)
By: Marija Popova-Labachevska,  Milche Cvetanoski,  Nevenka Ridova,  Sanja Trajkova,  Simona Stojanovska-Jakimovska,  Tara Mojsovska,  Zlate Stojanoski,  Aleksandra Pivkova-Veljanovska and  Irina Panovska-Stavridis  
Open Access
|Dec 2023

Authors

Marija Popova-Labachevska

marijapopova85@yahoo.com

University clinic of hematology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, RN Macedonia

Milche Cvetanoski

University clinic of hematology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, RN Macedonia

Nevenka Ridova

University clinic of hematology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, RN Macedonia

Sanja Trajkova

University clinic of hematology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, RN Macedonia

Simona Stojanovska-Jakimovska

University clinic of hematology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, RN Macedonia

Tara Mojsovska

University clinic of hematology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, RN Macedonia

Zlate Stojanoski

University clinic of hematology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, RN Macedonia

Aleksandra Pivkova-Veljanovska

University clinic of hematology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, RN Macedonia

Irina Panovska-Stavridis

dr_irina@yahoo.com

University clinic of hematology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, RN Macedonia
DOI: https://doi.org/10.2478/prilozi-2023-0047 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Journal RSS Feed
Language: English
Page range: 57 - 62
Published on: Dec 18, 2023
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Essential Thrombocythemia,
Polycythemia Vera,
Primary Myelofibrosis,
myeloproliferative neoplasms,
ropeginterferon alfa-2b
Related subjects:
Medicine,
Basic medical science,
History and ethics of medicine,
Clinical medicine,
Clinical medicine, other,
Social sciences,
Education,
Education, other

© 2023 Marija Popova-Labachevska, Milche Cvetanoski, Nevenka Ridova, Sanja Trajkova, Simona Stojanovska-Jakimovska, Tara Mojsovska, Zlate Stojanoski, Aleksandra Pivkova-Veljanovska, Irina Panovska-Stavridis, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 44 (2023): Issue 3 (December 2023)Next article